Literature DB >> 12843617

Fibrates and statins rapidly and synergistically induce pyruvate dehydrogenase kinase 4 mRNA in the liver and muscles of mice.

Kiyoto Motojima1, Kouichi Seto.   

Abstract

We previously identified pyruvate dehydrogenase kinase 4 (PDK4) mRNA as a most rapidly induced mRNA by fibrates and suggested the possibility that the coupled induction of PDK4 and reduction of serum triglyceride and fatty acid levels can cause protein degradation in muscles. To investigate whether the drugs that are known to have a risk of rhabdomyolysis induce PDK4 mRNA in skeletal muscle, the effects of statins and new quinolon anti-bacterial drugs on the expression levels of the mRNA were examined using mice and cultured cells. Several statins and new quinolon anti-bacterial drugs solely induced PDK4 mRNA in the muscle as efficiently as fibrates and at least some combinations were synergistic. The present results suggest that induction of PDK4 mRNA is involved in the drug induced acute rhabdomyolysis when the muscle is restricted to use fatty acids as a major energy source.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12843617     DOI: 10.1248/bpb.26.954

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  9 in total

1.  Additive effects of clofibric acid and pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) deficiency on hepatic steatosis in mice fed a high saturated fat diet.

Authors:  Byounghoon Hwang; Pengfei Wu; Robert A Harris
Journal:  FEBS J       Date:  2012-04-04       Impact factor: 5.542

Review 2.  Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance.

Authors:  Geoffrey A Preidis; Kang Ho Kim; David D Moore
Journal:  J Clin Invest       Date:  2017-03-13       Impact factor: 14.808

3.  PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle.

Authors:  Despina Constantin; Dumitru Constantin-Teodosiu; Robert Layfield; Kostas Tsintzas; Andrew J Bennett; Paul L Greenhaff
Journal:  J Physiol       Date:  2007-05-31       Impact factor: 5.182

4.  Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy.

Authors:  Joanne E Mallinson; Dumitru Constantin-Teodosiu; James Sidaway; F Russell Westwood; Paul L Greenhaff
Journal:  J Physiol       Date:  2008-11-10       Impact factor: 5.182

Review 5.  Targeting Cancer Metabolism - Revisiting the Warburg Effects.

Authors:  Quangdon Tran; Hyunji Lee; Jisoo Park; Seon-Hwan Kim; Jongsun Park
Journal:  Toxicol Res       Date:  2016-07-30

Review 6.  PPAR-Mediated Toxicology and Applied Pharmacology.

Authors:  Yue Xi; Yunhui Zhang; Sirui Zhu; Yuping Luo; Pengfei Xu; Zhiying Huang
Journal:  Cells       Date:  2020-02-03       Impact factor: 6.600

7.  Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents.

Authors:  Joanne E Mallinson; Dumitru Constantin-Teodosiu; Philip D Glaves; Elizabeth A Martin; Wendy J Davies; F Russell Westwood; James E Sidaway; Paul L Greenhaff
Journal:  J Physiol       Date:  2012-10-08       Impact factor: 5.182

8.  Genetic inactivation of pyruvate dehydrogenase kinases improves hepatic insulin resistance induced diabetes.

Authors:  Rongya Tao; Xiwen Xiong; Robert A Harris; Morris F White; Xiaocheng C Dong
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

Review 9.  Integrated physiology and systems biology of PPARα.

Authors:  Sander Kersten
Journal:  Mol Metab       Date:  2014-03-06       Impact factor: 7.422

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.